What caught my eye today, as the world is focused on NVIDIA and whether or not we’re at a real inflection point for AI spending, was something completely different: A teaser pitch about gold and Tether from Marin Katusa. His tease was fairly light on the “promotion,” this wasn’t a big splashy presentation — but in his free letter late last week he talked up the inevitability of gold’s rise as the central banks keep buying to diversify away from the U.S. dollar, and as the cryptocurrency companies find ways ...

Core Viewpoint - NatBridge Resources Ltd. has extended its binding Letter of Intent with Teras Resources Inc. for the acquisition of the Cahuilla Gold Project, reflecting a commitment to advance the project and align with its strategy in the gold resource sector [1][3]. Transaction Overview - The deadline for entering a definitive agreement for the purchase of the Cahuilla Gold Project subsurface rights has been extended to September 26, 2025, while all other terms of the original LOI remain unchanged [2][9]. - The acquisition involves obtaining 100% of the subsurface mineral rights for Parcels 45 and 46, which contain an indicated resource of 122,211 ounces of gold at a 0.005 oz/ton cut-off [4][9]. Project Details - The Cahuilla Gold Project spans approximately 1,680 acres in Imperial County, California, with a focus on Parcels 45 and 46, which are wholly owned by Teras Resources [4]. - The indicated resource for Parcel 45 is 50,251 ounces of gold and 511,227 ounces of silver, while Parcel 46 has 71,960 ounces of gold and 858,856 ounces of silver [14]. Assessment Report - An independent assessment report by Capps Geoscience LLC confirmed Teras Resources' ownership and title to the parcels, and validated the mineral resource estimates [5][6]. - The assessment was based on a comprehensive database of 441 drill holes, confirming the integrity of the resource estimate [14]. Strategic Positioning - NatBridge aims to build a portfolio of gold properties that meet the tokenization requirements set by NatGold Digital Ltd., positioning itself at the forefront of sustainable, blockchain-powered gold resource management [3][11]. - The company's strategy focuses on the supply side of NatGold Digital's digital gold tokenization ecosystem, which aims to redefine gold's value capture through eco-friendly processes [11].

Group 1 - BioSig Technologies, Inc. has merged with Streamex Exchange Corporation, focusing on gold tokenization infrastructure for on-chain gold markets [1] - The company will participate in the 5th annual Needham Virtual Crypto 1x1 Conference on September 4, 2025, where its CEO and CIO will hold one-on-one meetings with institutional investors [1] - Streamex aims to build institutional-grade infrastructure for the gold market, supported by a gold-denominated treasury and tokenization technology [2] Group 2 - BioSig Technologies specializes in medical device technology, particularly with its PURE EP™ Platform that provides insights for electrophysiologists in treating cardiovascular arrhythmias [3]

Core Viewpoint - BioSig Technologies, Inc. has successfully closed an underwritten public offering to support its merger with Streamex Exchange Corporation, focusing on gold tokenization infrastructure [1][2][3]. Group 1: Offering Details - The offering included 3,852,149 shares of common stock priced at $3.90 per share, generating gross proceeds of approximately $15,023,381 before expenses [2]. - The net proceeds will be utilized for purchasing gold bullion, general corporate purposes, and working capital [2]. Group 2: Strategic Intent - The CEO of BioSig emphasized the importance of aligning short and long-term capital strategies with high-quality shareholders to enhance shareholder value [3]. - The company aims to establish itself as a leader in the gold bullion-based real-world asset space, leveraging the recent capital raise [3]. Group 3: Company Background - Streamex is focused on building institutional-grade infrastructure for gold tokenization, supported by a gold-denominated treasury [6]. - BioSig Technologies is a medical device company known for its PURE EP™ Platform, which aids electrophysiologists in treating cardiovascular arrhythmias [7][8].